Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins.
Ben Redjeb
S
S
Ben Yaghlane
H
H
Boujnah
A
A
Philippon
A
A
Labia
R
R
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000008:administration & dosage*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004755:Enterobacteriaceae / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D019818:Clavulanic Acid